StonvexLoading…
StonvexStonvexStonvexCore line items from SCND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.23M | $5.05M | $3.43M | $4.74M |
Operating Income | $-1.67M | $-7.89M | $-5.43M | $-3.36M |
Net Income | $-1.59M | $-1.22M | $692.20K | $-3.30M |
EPS (Diluted) | $-0.13 | $-0.11 | $0.06 | $-0.30 |
Total Assets | $11.10M | $12.61M | $14.56M | $10.23M |
Total Liabilities | $1.99M | $1.94M | $2.10M | $2.23M |
Cash & Equivalents | $797.80K | $955.00K | $1.16M | $891.40K |
Free Cash Flow OCF − CapEx | $-999.70K | $-8.21M | $-4.43M | $-2.80M |
Shares Outstanding | 11.93M | 11.93M | 11.93M | 11.55M |